Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 26-02 / BIG 4-02 (PERCHE) 

A phase III trial evaluating the role of chemotherapy as adjuvant therapy for premenopausal women with endocrine responsive breast cancer who receive endocrine therapy

Premenopausal Endocrine Responsive Chemotherapy Trial (PERCHE)

DESIGN

please click on the picture to see a larger version

Results & Publications


Posters


Presentations

Study Chairs
BIG: Dr. Rosalba Torrisi - Milano, Italy
US Intergroup: Dr. Edith A. Perez - Jacksonville, USA

Statistician
Dr. Meredith Regan

Trial Coordinators
Holly Shaw, Renaye Hecker, Vanessa Palermo

Data Managers
Karolyn Scott, Jocelyn Swick, Monica Greco, Adriana Mora de Karausch, Adrianna Cesario, Amy Dickinson, Monique Fortunato, Kimberly Lupejkis, Vanessa Palermo

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 836 6097
Email: ibcsg24-26_STP@fstrf.org

Date of Activation
August 4, 2003

Date of Closure
December 31, 2006

Targeted Accrual
1750 patients

Final Accrual
29 patients


Results Publications Results & Publications
Other Pathology


News

21.05.2013:
A few impressions from our audits

10.04.2013:
New publications are available

19.03.2013:
The next  IBCSG Annual Meeting will take place in Glasgow, Scotland on March 21nd and 22th, 2014.

All News

 
  Print